STAT3 gain-of-function mutations associated with autoimmune lymphoproliferative syndrome like disease deregulate lymphocyte apoptosis and can be targeted by BH3 mimetic compounds

STAT3 gain-of-function mutations associated with autoimmune lymphoproliferative syndrome like disease deregulate lymphocyte apoptosis and can be targeted by BH3 mimetic compounds

Copyright © 2017 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 181(2017) vom: 02. Aug., Seite 32-42
1. Verfasser: Nabhani, Schafiq (VerfasserIn)
Weitere Verfasser: Schipp, Cyrill, Miskin, Hagit, Levin, Carina, Postovsky, Sergey, Dujovny, Tal, Koren, Ariel, Harlev, Dan, Bis, Anne-Marie, Auer, Franziska, Keller, Baerbel, Warnatz, Klaus, Gombert, Michael, Ginzel, Sebastian, Borkhardt, Arndt, Stepensky, Polina, Fischer, Ute
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2017
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't ABT-737 ALPS Apoptosis BCL-2 BH3-mimetic inhibitor STAT3 Biphenyl Compounds FAS protein, human mehr... FASLG protein, human Fas Ligand Protein Nitrophenols Piperazines Proto-Oncogene Proteins c-bcl-2 STAT3 Transcription Factor STAT3 protein, human Sulfonamides fas Receptor Butylated Hydroxytoluene 1P9D0Z171K BH 3 728-39-2
Online verfügbar Volltext